ReP USP - Resultado da busca

Filtros : "Goodyear, Carl S." Limpar

Filtros

USP affiliated authors
- alves filho, josé carlos farias (~1)
- lacchini, silvia (~1)
Date published
- 2019 (~1)
- 2012 (~1)
Subjects
- anatomia (1)
- doenças autoimunes (experimentação) (1)
- doenças cardiovasculares (1)
- enzimas (1)
- inflamação (1)

Collaboration
Normalized affiliation
- university of strathclyde (us) (~1)
Non normalized affiliation
- 3rd department of internal medicine, papageorgiou hospital, aristotle university of thessaloniki, thessaloniki, greece (1)
- centre of immunobiology, institute of infection, immunity and inflammation, college of medical, veterinary and life sciences, university of glasgow, glasgow, uk (1)
- department of pharmacology, rutgers robert wood johnson medical school, new brunswick, nj, usa (1)
- institute of cardiovascular and medical sciences, bhf glasgow cardiovascular research centre, university of glasgow, 126 university place, glasgow g12 8ta, uk (1)
- lewis sigler institute of integrative genomics, princeton university, princeton, nj, usa (1)

Artigo de periodico
Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis (2019)
Rios, Francisco J.; Zou, Zhi-Guo; Harvey, Adam P.; Harvey, Katie Y. ; Nosalski, Ryszard; Anyfanti, Panagiota; Camargo, Livia de Lucca ; Lacchini, Silvia ; Ryazanov, Alexey G.; Ryazanova, Lillia; McGrath, Sarah; Guzik, Tomasz J.; Goodyear, Carl S. ; Montezano, Augusto C.; Touyz, Rhian M.
Source: Cardiovascular Research. Unidade: ICB
Subjects: ANATOMIA, INFLAMAÇÃO, ENZIMAS, DOENÇAS CARDIOVASCULARES, SISTEMA CARDIOVASCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIOS, Francisco J. et al. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. Cardiovascular Research, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvz164. Acesso em: 03 nov. 2024.
APA
Rios, F. J., Zou, Z. -G., Harvey, A. P., Harvey, K. Y., Nosalski, R., Anyfanti, P., et al. (2019). Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis. Cardiovascular Research, 1-15. doi:10.1093/cvr/cvz164
NLM
Rios FJ, Zou Z-G, Harvey AP, Harvey KY, Nosalski R, Anyfanti P, Camargo L de L, Lacchini S, Ryazanov AG, Ryazanova L, McGrath S, Guzik TJ, Goodyear CS, Montezano AC, Touyz RM. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis [Internet]. Cardiovascular Research. 2019 ; 1-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/cvr/cvz164
Vancouver
Rios FJ, Zou Z-G, Harvey AP, Harvey KY, Nosalski R, Anyfanti P, Camargo L de L, Lacchini S, Ryazanov AG, Ryazanova L, McGrath S, Guzik TJ, Goodyear CS, Montezano AC, Touyz RM. Chanzyme TRPM7 protects against cardiovascular inflammation and fibrosis [Internet]. Cardiovascular Research. 2019 ; 1-15.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1093/cvr/cvz164
Artigo de periodico
IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages (2012)
Jiang, Hui-Rong; Milovanovic, Marija; Allan, Debbie; Niedbala, Wanda; Besnard, Anne-Galle; Fukada, Sandra Y.; Alves Filho, José Carlos Farias; Togbe, Dieudonnée; Goodyear, Carl S.; Linington, Christopher; Xu, Damo; Lukic, Miodrag L.; Liew, Foo Y.
Source: European Journal of Immunology. Unidade: FMRP
Subjects: MACRÓFAGOS, DOENÇAS AUTOIMUNES (EXPERIMENTAÇÃO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIANG, Hui-Rong et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages. European Journal of Immunology, v. 42, n. 7, p. 1804-1814, 2012Tradução . . Disponível em: https://doi.org/10.1002/eji.201141947. Acesso em: 03 nov. 2024.
APA
Jiang, H. -R., Milovanovic, M., Allan, D., Niedbala, W., Besnard, A. -G., Fukada, S. Y., et al. (2012). IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages. European Journal of Immunology, 42( 7), 1804-1814. doi:10.1002/eji.201141947
NLM
Jiang H-R, Milovanovic M, Allan D, Niedbala W, Besnard A-G, Fukada SY, Alves Filho JCF, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages [Internet]. European Journal of Immunology. 2012 ; 42( 7): 1804-1814.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/eji.201141947
Vancouver
Jiang H-R, Milovanovic M, Allan D, Niedbala W, Besnard A-G, Fukada SY, Alves Filho JCF, Togbe D, Goodyear CS, Linington C, Xu D, Lukic ML, Liew FY. IL-33 attenuates EAE by suppressing IL-17 and IFN-y production and inducing alternatively activated macrophages [Internet]. European Journal of Immunology. 2012 ; 42( 7): 1804-1814.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1002/eji.201141947

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024